techMARK: A focus on innovation

techMARK and techMARK mediscience are specialist segments of the Main Market focusing on innovative technology and healthcare companies.          

The Main Market is the only market to provide a focus of this type, reflecting the Exchange’s recognition of technological innovation as a driver of global economic and social development.

Benefits of techMARK

  • Clear identification as an innovative company operating in technology and/or healthcare
  • Membership of a community committed to investing in research and development
  • Increased investor and media awareness through inclusion in the FTSE techMARK Index Series and associated funds

techMARK is supported by an independent panel of industry experts – the techMARK Admissions Panel. With representation from trade bodies, the corporate finance, fund management, legal and accounting professions, the Panel advises on the eligibility of specific companies for techMARK and techMARK mediscience and reviews as appropriate the overall approach to eligibility.

For more information on joining techMARK and techMARK mediscience please contact the Exchange’s Business Development team on 020 7797 3429 or email equityprimarymarkets@lseg.com.